Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Initiation of SGLT2 Inhibitors After Myocardial Infarction to Reduce Heart Failure Events
TCTR20211024002Phase 3Completed
- Sponsor
- Thailand Science Research and Innovation
- Start
- Dec 2021
- Countries
- 1
01
Overview
Phase 3 trial in myocardial infarction (MI) and heart failure (HF), sponsored by Thailand Science Research and Innovation. Started Dec 2021; status: completed.
02
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on TCTR20211024002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211024002.